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We read with interest the recent report by Gogos and 
colleagues [1]. While the rationale for their study is 
excellent, we would like to comment on technical issues 
that may have inﬂ  uenced the results.
As stated, a time limit of 8 hours between sample 
drawing and staining at a central laboratory was speciﬁ  ed 
[1]. Unfortunately, information regarding transport con-
ditions is missing (average time, temperature). Th  is  seems 
important since monocytic HLA-DR expression (mHLA-
DR) increases artiﬁ  cially over time [2,3]. Conse  quently, 
recommendations suggest that sample staining for 
mHLA-DR should occur within 4 hours [2,3]. Although 
the authors aimed to address the eﬀ  ect of transportation, 
they inappropriately used samples present  ing with 
already near-maximal mHLA-DR values (>90%) before 
storage. We therefore assume that mHLA-DR results 
may be falsely elevated due to prolonged transportation 
times. Furthermore, mHLA-DR modulation during sepsis 
takes days and consecutive measurements are required 
[4]. Assessment of one early sample (within the ﬁ  rst 
24  hours) is probably inappropriate to investigate the 
impact of infection on mHLA-DR. Similarly, apoptosis 
staining should not be performed after 8 hours and 
experts’ recommendations highlight the need for 
dedicated protocols on fresh cells [5].
We are convinced that successful future trials in sepsis 
will rely on our capacity to accurately assess immune 
responses. In that sense, ﬂ   ow cytometry multicentric 
clinical studies are essential. Such trials should be 
performed in standardized environments in accordance 
with speciﬁ   c (pre)analytical requirements. Otherwise, 
results might be misinterpreted and may impede 
promising new avenues in future care of septic patients.
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